NewGenIvf Group Limited

NewGenIvf Group Limited is a diversified healthcare and technology-driven platform, initially established as a comprehensive provider of assisted reproductive services (ARS) across the Asia Pacific region. Headquartered in Bangkok, Thailand, the company operates as a British Virgin Islands holding company with subsidiaries in the Cayman Islands and key Asian markets including Hong Kong, Thailand, Kyrgyzstan, and Cambodia. Its core mission is to empower individuals and couples in achieving their parenthood aspirations by offering advanced and accessible fertility treatments.

The company's service portfolio encompasses a wide range of fertility solutions, including In-Vitro Fertilization (IVF), ICSI, embryo culture, egg donation, and surrogacy services, delivered through its network of clinics. Beyond its foundational ARS business, NewGenIvf Group has strategically diversified into new market segments, establishing divisions for real estate development (NewGenProperty), digital assets and decentralized finance (NewGenDigital), and health and longevity products (NewGenSup). A notable expansion in February 2025 included the acquisition of MicroSort and its associated patent portfolio, enhancing its position in innovative fertility solutions.

NewGenIvf Group Limited became a publicly traded entity on the Nasdaq Capital Market under the ticker "NIVF" on April 4, 2024, following a business combination. Recent strategic initiatives include a pivot towards a technology-driven model, focusing on licensing and royalties from advanced reproductive technologies like cytometry and sperm-sorting. The company is also actively involved in digital asset tokenization, including a private art collection and real estate projects in the UAE. In a move to tap into the growing medical tourism market, its subsidiary, First Fertility PGS Center, launched specialized services for Indian medical tourists in Thailand in May 2025. The company's 2024 annual report, filed in April 2025, underscored its robust financial standing.